The need for completion thyroidectomy is determined by the oncological risks: risk of cancer recurrence, the indication for adjuvant radioiodine therapy or ablation, and the need to have a reliable and sensitive tumor marker—serum thyroglobulin (Tg)—to detect recurrences. The gene discussed is TG; the disease is neoplasm.